These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 22247242)

  • 61. Critical heart defects--the diagnostic challenge.
    Meberg A
    Acta Paediatr; 2008 Nov; 97(11):1480-3. PubMed ID: 18671689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects.
    Sendelbach DM; Jackson GL; Lai SS; Fixler DE; Stehel EK; Engle WD
    Pediatrics; 2008 Oct; 122(4):e815-20. PubMed ID: 18762486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pulse oximetry screening of newborns detects congenital heart defects. Experiences from Kalmar].
    Green E; Rosenkvist CJ
    Lakartidningen; 2012 Feb 29-Mar 13; 109(9-10):481-2. PubMed ID: 22530413
    [No Abstract]   [Full Text] [Related]  

  • 64. Smooth implementation of critical congenital heart defect screening in a newborn nursery.
    Andrews JP; Ross AS; Salazar MA; Tracy NA; Burke BL
    Clin Pediatr (Phila); 2014 Feb; 53(2):173-6. PubMed ID: 24037922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pulse oximetry screening for congenital heart defects in Switzerland: most but not all maternity units screen their neonates.
    Kuelling B; Arlettaz Mieth R; Bauersfeld U; Balmer C
    Swiss Med Wkly; 2009 Nov; 139(47-48):699-704. PubMed ID: 20047132
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Newborn pulse oximetry screening for critical congenital heart defects.
    Jullien S
    BMC Pediatr; 2021 Sep; 21(Suppl 1):305. PubMed ID: 34496777
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The value of peripheral perfusion index measurements for early detection of critical cardiac defects.
    Uygur O; Koroglu OA; Levent E; Tosyali M; Akisu M; Yalaz M; Kultursay N
    Pediatr Neonatol; 2019 Feb; 60(1):68-73. PubMed ID: 29776787
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Maternal acceptability of pulse oximetry screening at home after home birth or very early discharge.
    Narayen IC; Kaptein AA; Hogewoning JA; Blom NA; Te Pas AB
    Eur J Pediatr; 2017 May; 176(5):669-672. PubMed ID: 28281093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of Neonates With Suspected Congenital Heart Disease: A New Cost-Effective Algorithm.
    Minocha P; Agarwal A; Jivani N; Swaminathan S
    Clin Pediatr (Phila); 2018 Nov; 57(13):1541-1548. PubMed ID: 30094999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pulse oximetry screening for critical congenital heart disease in the newborn.
    Ramjattan K; Allen PJ
    Pediatr Nurs; 2013; 39(5):250-3, 256. PubMed ID: 24308092
    [No Abstract]   [Full Text] [Related]  

  • 71. Neonatal screening for critical cardiovascular anomalies using pulse oximetry.
    Prudhoe S; Abu-Harb M; Richmond S; Wren C
    Arch Dis Child Fetal Neonatal Ed; 2013 Jul; 98(4):F346-50. PubMed ID: 23341250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of critical congenital heart disease newborn screening at moderate altitude.
    Wright J; Kohn M; Niermeyer S; Rausch CM
    Pediatrics; 2014 Mar; 133(3):e561-9. PubMed ID: 24567022
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for Critical Congenital Heart Disease in Newborns.
    Bruno CJ; Havranek T
    Adv Pediatr; 2015 Aug; 62(1):211-26. PubMed ID: 26205115
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Review of pulse oximetry screening for critical congenital heart defects in newborn infants.
    Ewer AK
    Curr Opin Cardiol; 2013 Mar; 28(2):92-6. PubMed ID: 23381095
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Temporal trends in routine predischarge pulse oximetry screening: 6 years' experience in a UK regional neonatal unit.
    Henderson A; Aguirre D; Singh A; Ewer AK
    Arch Dis Child Fetal Neonatal Ed; 2022 May; 107(3):256-261. PubMed ID: 34686534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quality improvement measures in pulse-oximetry newborn heart screening: a time series analysis.
    Pflugeisen BM; Amoroso PJ; Zook D; Welke KF; Reedy A; Park MV
    Pediatrics; 2015 Feb; 135(2):e531-9. PubMed ID: 25601984
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The nurse champion model for advancing newborn screening of critical congenital heart disease.
    Farner R; Livingston J; Rubio SA; Gutierrez MV; Gong A;
    J Obstet Gynecol Neonatal Nurs; 2014; 43(4):497-506. PubMed ID: 24980275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants: the importance of human factors.
    Reich JD; Connolly B; Bradley G; Littman S; Koeppel W; Lewycky P; Liske M
    Pediatr Cardiol; 2008 Mar; 29(2):371-6. PubMed ID: 17932712
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease.
    Rosati E; Chitano G; Dipaola L; De Felice C; Latini G
    J Perinat Med; 2005; 33(5):455-7. PubMed ID: 16238542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.